Long-term headaches in children with idiopathic intracranial hypertension—a 10 years follow-up
-
By
-
Jacob Genizi
-
Moran Cymbrowicz
-
Lilach Shemer-Meiri
-
Noam Ganz
-
Ayellet Sadeh
-
Rony Cohen
-
Rajech Sharkia
-
Abdelnaser Zalan
-
Salam Abd El Karim Murad
-
Esther Ganelin-Cohen
-
Muhammad Mahajnah
-
May 14, 2026
-
Clinical Scorecard: Persistent Headaches in Pediatric Patients with Idiopathic Intracranial Hypertension: A Decade of Follow-Up
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Increased intracranial pressure due to impaired cerebrospinal fluid absorption, altered cerebral venous outflow, and metabolic–hormonal influences. |
| Target Population | |
| Care Setting | |
Key Highlights
- 58% of patients reported persistent headaches 10 years post-diagnosis, with significant impacts on quality of life.
Guideline-Based Recommendations
Diagnosis
Management
- Acetazolamide as first-line therapy; CSF shunting for severe cases, especially in refractory patients.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Short-term improvement common; long-term headache outcomes remain poorly understood, with factors such as BMI and age influencing persistence.
Clinical Best Practices
- Emphasize urgent ophthalmological evaluation at diagnosis.
- Monitor quality of life using validated questionnaires like WHOQOL-BREF.
- Regular follow-up for headache severity and quality of life assessment.
Related Resources & Content
